| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080113973 Pharmaceutical composition in unit dose form which contains a COX-2 inhibitor and a thromboxane A2 receptor antagonist; for treatment of pain or inflammation; less risk of inducing adverse cardiovascular effects than when COX-2 inhibitors are administered alone |
| 05/15/2008 | US20080113960 Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113903 Prevent mammals tissue injuries |
| 05/15/2008 | US20080113899 Iron Supplement and Utilization of the Same |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | DE112006001853T5 Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten Pharmaceutical compositions containing Clopidogrel bisulfate |
| 05/15/2008 | DE102006052755A1 New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease |
| 05/15/2008 | CA2667488A1 Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
| 05/14/2008 | EP1921094A2 Method for presenting and removing substances |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1919498A2 Liquid factor vii composition |
| 05/14/2008 | EP1919483A1 Combined preparation of a thiazide diuretic and a loop diuretic |
| 05/14/2008 | EP1633440B1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1461049B1 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1274728B1 Methods and compositions for the prevention and treatment of anemia |
| 05/14/2008 | EP1198242B1 Autologous thrombin |
| 05/14/2008 | CN101180296A Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors |
| 05/14/2008 | CN101176785A Regrouping bi-functional leech essence oral preparation and preparation method thereof |
| 05/14/2008 | CN101176772A Pharmaceutical composition made of cattail pollen and safflower |
| 05/14/2008 | CN101176769A Pharmaceutical composition of cattail pollen and red orpin |
| 05/14/2008 | CN101176751A Pharmaceutical composition of red sage root and cassia twig |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387296C New dialysis method |
| 05/14/2008 | CN100387292C Chinese medicine preparation for treating leukemia |
| 05/14/2008 | CN100387242C American ginseng and royal jelly soft capsule |
| 05/14/2008 | CN100387222C Solid preparation for dialysis and process for producing the same |
| 05/14/2008 | CN100387221C Preparation method of Chinese mugwort injection |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2213322C Thiols to promote hematopoietic progenitor cell growth |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008054290A1 1h-pyridine- 2 -one derivatives useful in treatment of pai-1 related disorders |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008053602A1 5-(1h-1,2,3-triazol-4-yl)-1h-pyrazole derivative |
| 05/08/2008 | WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | WO2008052671A2 Combination therapy of substituted oxazolidinones |
| 05/08/2008 | WO2008034623A3 Medicament for the prophylaxis, treatment or diagnosis of ischaemic diseases |
| 05/08/2008 | US20080108712 diagnosing and/or treating patients that either have or are at risk for developing cardiovascular disorders; diabetic patient or on hormone replacement therapy; biodrugs; determining the identity of the nucleotide at position -54,642 of a nucleotide sequence; microarrays |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108594 Antithrombotic Ethers |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108589 Method of treatment with coadministration of aspirin and prasugrel |
| 05/08/2008 | US20080108567 Leptin-related peptides |
| 05/08/2008 | US20080108564 Peptide covalently bound to Polyethylene glycol; agonists of the erythropoietin receptor (EPO-R), having amino acid sequence; defective red blood cell production |
| 05/08/2008 | US20080108555 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080107759 Bamboo of Sasa genus or Phyllostachys genus; extracted with water, alcohol, non-polar hexane, ethyl acetate, chloroform and dichloromethane |
| 05/08/2008 | US20080107678 Such as fucoidans from Fucus vesiculosis or Laminaria japonica (seaweeds); anticoagulants; kits |
| 05/08/2008 | US20080107677 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 05/08/2008 | US20080107654 Immunloglobulin specific for calcium transport membrane protein for use in prevention and treatment of hematological disorders |
| 05/08/2008 | US20080107651 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 05/08/2008 | US20080107641 Treating ischemic events in humans via administration of tissue plasminogen activator; antiischemic agents |
| 05/08/2008 | DE102006051625A1 Kombinationstherapie substituierter Oxazolidinone Combination therapy substituted oxazolidinones |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1917070A1 Food product and fortification system therefor |
| 05/07/2008 | EP1917026A1 Stimulators of factor x activated (fxa) as new topical antihemorrhagic agents |
| 05/07/2008 | EP1628971B1 TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 05/07/2008 | EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 05/07/2008 | EP1513588B1 Use of new etonogestrel esters |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | CN101175756A Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 05/07/2008 | CN101175751A Crystal of indole derivative having piperidine ring and process for production thereof |
| 05/07/2008 | CN101173003A Hundred-paced pit viper toxin thrombinogen excitor, coded sequence and uses thereof |
| 05/07/2008 | CN101172997A Oligopeptide or its modified compound/derivant and application thereof |
| 05/07/2008 | CN101172959A N,N*-2[fluoroform (oxygen) group] substituted phenyl derivant of 4-methoxy-1,3-benzene diamide and uses of the same |
| 05/07/2008 | CN101172958A N,N*-2(2substituted phenyl) derivant of - 4-methoxy-1,3-benzol diamide and use of the same |
| 05/07/2008 | CN101172161A Water-soluble polymers decorated G-CSF conjugates |
| 05/07/2008 | CN101172141A Drug for curing coronary disease |
| 05/07/2008 | CN101172140A Nutritive composition for accelerating hemopoietic stem cell proliferation and hemoglobin synthesis |
| 05/07/2008 | CN101172131A Method for preparing potentilla plants total-triterpene extract |
| 05/07/2008 | CN101172129A Traditional Chinese medicine composition for treating hypodermal ecchymosis and method of preparing the same |
| 05/07/2008 | CN101172112A Compound with special property, composition containing the compound, preparing method and uses of the same |
| 05/07/2008 | CN100386433C White-browed snake venom blood coagulation enzyme and its extraction method and application |
| 05/07/2008 | CN100386079C Injection use-powder ampoule for inhibiting thrombocyte agglutination and its preparation method |
| 05/07/2008 | CN100386072C Nanometer dragon's blood capsule and its preparation method |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368471 fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis, Alzheimer's disease; {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368450 Sodium channel blockers |